Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney disease.
From the Department of Cardiovascular Medicine, Omi Medical Center, Kusatsu, Japan, Department of Cardiovascular Medicine,
@KyotoU_News Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan & Department of clinical trial facilitation, Kyoto University Graduate School of Medicine, Kyoto, Japan
@drkarthik2010 @BoopathyCardio @mvaduganathan @EricTopol @kamleshkhunti
bit.ly/44QmPMT